Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicolas Alan Menzies, Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI146555 (MENZIES, NICOLAS A) Dec 5, 2019 - Nov 30, 2024
    NIH/NIAID
    Optimal targeting for individual and population-level TB prevention
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Earnest R, Rönn MM, Bellerose M, Gift TL, Berruti AA, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis. Sex Transm Dis. 2020 07; 47(7):484-490. PMID: 32355108.
    Citations:    
  2. Portnoy A, Vaughan K, Clarke-Deelder E, Suharlim C, Resch SC, Brenzel L, Menzies NA. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. Pharmacoeconomics. 2020 Jun 28. PMID: 32596785.
    Citations:    
  3. Yaesoubi R, Havumaki J, Chitwood M, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic. medRxiv. 2020 Jun 01. PMID: 32577698.
    Citations:    
  4. Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies NA, Danaei G, Verguet S. Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa. J Int AIDS Soc. 2020 Jun; 23 Suppl 1:e25508. PMID: 32562370.
    Citations:    
  5. Sando D, Kintu A, Okello S, Kawungezi PC, Guwatudde D, Mutungi G, Muyindike W, Menzies NA, Danaei G, Verguet S. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020 Jun; 23 Suppl 1:e25507. PMID: 32562364.
    Citations:    
  6. Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H, Menzies NA, Strong M, Thom H, Heath A. Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value Health. 2020 Jun; 23(6):734-742. PMID: 32540231.
    Citations:    
  7. Pitzer VE, Chitwood M, Havumaki J, Menzies NA, Perniciaro S, Warren JL, Weinberger DM, Cohen T. The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. medRxiv. 2020 Apr 24. PMID: 32511624.
    Citations:    
  8. Heath A, Kunst N, Jackson C, Strong M, Alarid-Escudero F, Goldhaber-Fiebert JD, Baio G, Menzies NA, Jalal H. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Med Decis Making. 2020 Apr; 40(3):314-326. PMID: 32297840.
    Citations:    
  9. Rönn MM, Menzies NA, Gift TL, Chesson HW, Trikalinos TA, Bellerose M, Malyuta Y, Berruti A, Gaydos CA, Hsu KK, Salomon JA. Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis. Clin Infect Dis. 2020 Apr 15; 70(9):1816-1823. PMID: 31504314.
    Citations:    
  10. Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Sci Rep. 2020 Apr 14; 10(1):6348. PMID: 32286412.
    Citations:    
  11. McGough SF, Johansson MA, Lipsitch M, Menzies NA. Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking. PLoS Comput Biol. 2020 04; 16(4):e1007735. PMID: 32251464.
    Citations:    
  12. Rönn MM, Testa C, Tuite AR, Chesson HW, Gift TL, Schumacher C, Williford SL, Zhu L, Bellerose M, Earnest R, Malyuta Y, Hsu KK, Salomon JA, Menzies NA. The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis. Sex Transm Dis. 2020 03; 47(3):143-150. PMID: 31842089.
    Citations:    
  13. Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, van Kampen S, Marx FM, Sweeney S, Wallis RS, Menzies NA. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. Lancet Respir Med. 2020 Apr; 8(4):332-333. PMID: 32057300.
    Citations:    
  14. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. Am J Respir Crit Care Med. 2020 02 01; 201(3):356-365. PMID: 31626560.
    Citations:    
  15. Menzies NA, Suharlim C, Resch SC, Brenzel L. The efficiency of routine infant immunization services in six countries: a comparison of methods. Health Econ Rev. 2020 Jan 08; 10(1):1. PMID: 31916025.
    Citations:    
  16. Munk C, Portnoy A, Suharlim C, Clarke-Deelder E, Brenzel L, Resch SC, Menzies NA. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries. BMC Health Serv Res. 2019 Oct 22; 19(1):741. PMID: 31640687.
    Citations:    
  17. Clarke-Deelder E, Vassall A, Menzies NA. Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study. Value Health. 2019 10; 22(10):1146-1153. PMID: 31563257.
    Citations:    
  18. Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW. The Importance of Heterogeneity to the Epidemiology of Tuberculosis. Clin Infect Dis. 2019 06 18; 69(1):159-166. PMID: 30383204.
    Citations:    Fields:    
  19. Feldhaus I, Schütte C, Mwansa FD, Undi M, Banda S, Suharlim C, Menzies NA, Brenzel L, Resch SC, Kinghorn A. Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study. Health Policy Plan. 2019 Jun 01; 34(5):327-336. PMID: 31157376.
    Citations:    
  20. Isanaka S, Barnhart DA, McDonald CM, Ackatia-Armah RS, Kupka R, Doumbia S, Brown KH, Menzies NA. Cost-effectiveness of community-based screening and treatment of moderate acute malnutrition in Mali. BMJ Glob Health. 2019; 4(2):e001227. PMID: 31139441.
    Citations:    
  21. Menzies NA, McQuaid CF, Gomez GB, Siroka A, Glaziou P, Floyd K, White RG, Houben RMGJ. Improving the quality of modelling evidence used for tuberculosis policy evaluation. Int J Tuberc Lung Dis. 2019 04 01; 23(4):387-395. PMID: 31053179.
    Citations:    
  22. Rönn MM, Tuite AR, Menzies NA, Wolf EE, Gift TL, Chesson HW, Torrone E, Berruti A, Mazzola E, Galer K, Hsu K, Salomon JA. The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model. Am J Epidemiol. 2019 03 01; 188(3):545-554. PMID: 30608525.
    Citations:    Fields:    
  23. Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F. Spotting the old foe-revisiting the case definition for TB. Lancet Respir Med. 2019 03; 7(3):199-201. PMID: 30823971.
    Citations:    
  24. Houben RMGJ, Lalli M, Kranzer K, Menzies NA, Schumacher SG, Dowdy DW. What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis. Clin Infect Dis. 2019 01 01; 68(1):150-156. PMID: 29982375.
    Citations:    Fields:    
  25. Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T. Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. Lancet Infect Dis. 2019 03; 19(3):e89-e95. PMID: 30554997.
    Citations:    Fields:    
  26. Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. Int J Tuberc Lung Dis. 2018 12 01; 22(12):1392-1403. PMID: 30606311.
    Citations:    Fields:    
  27. Tuite AR, Rönn MM, Wolf EE, Gift TL, Chesson HW, Berruti A, Galer K, Menzies NA, Hsu K, Salomon JA. Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model. Sex Transm Dis. 2018 11; 45(11):713-722. PMID: 29894368.
    Citations:    Fields:    
  28. Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. Am J Epidemiol. 2018 09 01; 187(9):2011-2020. PMID: 29762657.
    Citations:    Fields:    
  29. Menzies NA, Cohen T, Salomon JA. Evidence sources on the natural history of latent tuberculosis infection. Lancet Infect Dis. 2018 08; 18(8):834-835. PMID: 30064672.
    Citations:    Fields:    
  30. Chatterjee S, Ghosh A, Das P, Menzies NA, Laxminarayan R. Determinants of cost of routine immunization programme in India. Vaccine. 2018 06 18; 36(26):3836-3841. PMID: 29776749.
    Citations: 1     Fields:    Translation:Humans
  31. Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018 08; 18(8):e228-e238. PMID: 29653698.
    Citations:    Fields:    
  32. Wallis RS, Cohen T, Menzies NA, Churchyard G. Pan-tuberculosis regimens: an argument for. Lancet Respir Med. 2018 04; 6(4):239-240. PMID: 29595501.
    Citations:    Fields:    Translation:HumansCells
  33. Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study. Lancet Glob Health. 2018 04; 6(4):e426-e435. PMID: 29472018.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  34. Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health. 2017 11; 5(11):e1123-e1132. PMID: 29025634.
    Citations: 2     Fields:    Translation:Humans
  35. Menzies NA, Suharlim C, Geng F, Ward ZJ, Brenzel L, Resch SC. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies. BMC Med. 2017 10 06; 15(1):178. PMID: 28982358.
    Citations: 1     Fields:    Translation:Humans
  36. Geng F, Suharlim C, Brenzel L, Resch SC, Menzies NA. The cost structure of routine infant immunization services: a systematic analysis of six countries. Health Policy Plan. 2017 Oct 01; 32(8):1174-1184. PMID: 28575193.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  37. Kiene SM, Kalichman SC, Sileo KM, Menzies NA, Naigino R, Lin CD, Bateganya MH, Lule H, Wanyenze RK. Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: study protocol for the Ekkubo/PATH cluster randomized controlled trial. BMC Infect Dis. 2017 07 03; 17(1):460. PMID: 28673251.
    Citations: 2     Fields:    Translation:Humans
  38. Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics. 2017 Jun; 35(6):613-624. PMID: 28247184.
    Citations: 1     Fields:    Translation:Humans
  39. Rönn MM, Wolf EE, Chesson H, Menzies NA, Galer K, Gorwitz R, Gift T, Hsu K, Salomon JA. The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review. Sex Transm Dis. 2017 05; 44(5):278-283. PMID: 28407643.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  40. Soeteman DI, Menzies NA, Pandya A. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information? Value Health. 2017 Jul - Aug; 20(7):894-901. PMID: 28712618.
    Citations:    Fields:    Translation:Humans
  41. Menzies NA, Gomez GB, Vassall A. Modelling approaches for tuberculosis: are they realistic? - Authors' reply. Lancet Glob Health. 2017 03; 5(3):e269. PMID: 28193392.
    Citations:    Fields:    Translation:Humans
  42. Isanaka S, Menzies NA, Sayyad J, Ayoola M, Grais RF, Doyon S. Cost analysis of the treatment of severe acute malnutrition in West Africa. Matern Child Nutr. 2017 10; 13(4). PMID: 27921381.
    Citations:    Fields:    Translation:Humans
  43. Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016 11; 4(11):e806-e815. PMID: 27720688.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  44. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016 11; 4(11):e816-e826. PMID: 27720689.
    Citations: 11     Fields:    Translation:Humans
  45. Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. J R Soc Interface. 2015 May 06; 12(106). PMID: 25878131.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  46. Menzies NA. An Efficient Estimator for the Expected Value of Sample Information. Med Decis Making. 2016 Apr; 36(3):308-20. PMID: 25911600.
    Citations: 1     Fields:    Translation:Humans
  47. Menzies NA, Cohen T, Murray M, Salomon JA. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. Lancet Infect Dis. 2015 Jan; 15(1):16-7. PMID: 25541164.
    Citations: 5     Fields:    Translation:HumansCells
  48. Dowdy DW, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies NA, Gomez GB, Langley I, Squire SB, White R. Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. Int J Tuberc Lung Dis. 2014 Sep; 18(9):1012-8. PMID: 25189546.
    Citations: 4     Fields:    Translation:Humans
  49. Hallett TB, Eaton JW, Menzies N. Beware of using invalid transmission models to guide HIV health policy - authors' reply. Lancet Glob Health. 2014 May; 2(5):e261. PMID: 25103163.
    Citations:    Fields:    Translation:Humans
  50. Hallett TB, Menzies NA, Revill P, Keebler D, Bórquez A, McRobie E, Eaton JW. Using modeling to inform international guidelines for antiretroviral treatment. AIDS. 2014 Jan; 28 Suppl 1:S1-4. PMID: 24468942.
    Citations: 3     Fields:    Translation:Humans
  51. Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS. 2014 Jan; 28 Suppl 1:S25-34. PMID: 24468944.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  52. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34. PMID: 25104632.
    Citations: 47     Fields:    Translation:Humans
  53. Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, Vizcaya LS, Walker S, Welte A, Easterbrook P, Doherty M, Hirnschall G, Hallett TB. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e35-43. PMID: 25104633.
    Citations: 16     Fields:    Translation:Humans
  54. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2013 Dec 10; 2(1):23-34. PMID: 25083415.
    Citations: 8     Fields:    
  55. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med. 2012; 9(11):e1001347. PMID: 23185139.
    Citations: 66     Fields:    Translation:HumansCells
  56. Menzies NA, Berruti AA, Blandford JM. The determinants of HIV treatment costs in resource limited settings. PLoS One. 2012; 7(11):e48726. PMID: 23144946.
    Citations: 22     Fields:    Translation:Humans
  57. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS. 2011 Sep 10; 25(14):1753-60. PMID: 21412127.
    Citations: 51     Fields:    Translation:HumansCells
  58. Menzies NA, Salomon JA. Non-monotonicity in the episodic random utility model. Health Econ. 2011 Dec; 20(12):1523-31. PMID: 22025393.
    Citations: 2     Fields:    Translation:Humans
  59. Menzies NA, Homsy J, Chang Pitter JY, Pitter C, Mermin J, Downing R, Finkbeiner T, Obonyo J, Kekitiinwa A, Tappero J, Blandford JM. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J. 2009 Sep; 28(9):819-25. PMID: 20050391.
    Citations: 7     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). FAS faculty should contact the Office for Scholarly Communication (oschulmail.harvard.edu) for general questions about Profiles. For data questions, please contact Raelyn Lincoln (raelyn_lincolnharvard.edu) from the FAS Division of Science; Jennifer Shephard (jmshephfas.harvard.edu) from the FAS Division of Social Science; or Alexander Parker (afparkerfas.harvard.edu) from the FAS Division of Arts and Humanities.
Menzies's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (172)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.